Press release
Investigation announced for Long-Term Investors in NASDAQ: TCDA shares over possible Wrongdoing at Tricida, Inc.
An investigation on behalf of current long term investors in Tricida, Inc. (NASDAQ: TCDA) shares.
Investors who are current long term investors in Tricida, Inc. (NASDAQ: TCDA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: TCDA stocks follows a lawsuit filed against Tricida, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: TCDA stocks, concerns whether certain Tricida, directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the Defendants made false and/or misleading statements and failed to disclose to investors that Tricida's NDA for veverimer was materially deficient, that accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Tricida, Inc. (NASDAQ: TCDA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in NASDAQ: TCDA shares over possible Wrongdoing at Tricida, Inc. here
News-ID: 2260774 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Tricida
Metabolic Acidosis Market Forecasted for Strong Growth from 2025 to 2032 | Tisen …
The metabolic acidosis market is estimated to be valued at USD 188.7 Mn in 2025 and is expected to reach USD 285.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
A new report from CoherentMI, titled "Metabolic Acidosis Market 2025-2032," offers an in-depth examination of the industry, including valuable insights into the Metabolic Acidosis Market's performance. The report covers competitor dynamics, regional…
Metabolic Acidosis Market 2025: Key Trends, Applications, and Technological Adva …
The metabolic acidosis market is estimated to be valued at USD 177.9 Mn in 2024 and is expected to reach USD 265.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.89% from 2024 to 2031.
According to the latest research from CoherentMI, the Metabolic Acidosis Market is projected to experience significant growth between 2025 and 2032. This market intelligence report offers in-depth analysis based on thorough…
Metabolic Acidosis Market Expected to rise, 2034 | Tisento Therapeutics, Tricida …
The Metabolic Acidosis market growth is driven by factors like increase in the prevalence of Metabolic Acidosis, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Metabolic Acidosis market report [https://www.delveinsight.com/report-store/metabolic-acidosis-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Metabolic Acidosis market size, share, Metabolic Acidosis epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and…
Chronic Kidney Disease Market Growth Projections 2024-2034: DelveInsight Analysi …
The Key Chronic Kidney Disease Companies in the market include - Tricida, Otsuka Pharmaceuticals, AstraZeneca, and others.
The Chronic Kidney Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Kidney Disease pipeline products will significantly revolutionize the Chronic Kidney Disease market dynamics.
DelveInsight's "Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of…
Chronic Kidney Disease Market and Epidemiology 2032: Treatment Market, Therapies …
The Chronic Kidney Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Kidney Disease pipeline products will significantly revolutionize the Chronic Kidney Disease market dynamics.
DelveInsight's "Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Kidney Disease, historical and forecasted epidemiology as well as the Chronic Kidney…
Deadline on March 8th coming up in Lawsuit for Investors in Tricida, Inc. (NASDA …
A deadline is coming up on March 8, 2021 in the lawsuit filed for certain investors of Tricida, Inc. (NASDAQ: TCDA) over alleged securities laws violations by Tricida, Inc.
Investors who purchased shares of Tricida, Inc. (NASDAQ: TCDA) have certain options and there are strict and short deadlines running. Deadline: March 8, 2021. NASDAQ: TCDA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
